Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd Coffey

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The AAPS Journal|April 5, 2017
Erratum to: Systematic Verification of Bioanalytical Similarity Between a Biosimilar and a Reference Biotherapeutic: Committee Recommendations for the Development and Validation of a Single Ligand-Binding Assay to Support Pharmacokinetic AssessmentsJoseph C Marini, Michael Anderson, Xiao-Yan Cai, et al.
The AAPS Journal|October 4, 2014
Systematic verification of bioanalytical similarity between a biosimilar and a reference biotherapeutic: committee recommendations for the development and validation of a single ligand-binding assay to support pharmacokinetic assessmentsJoseph C Marini, Michael Anderson, Xiao-Yan Cai, et al.
Science Translational Medicine|June 8, 2012
Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responsesSteven K Seung, Brendan D Curti, Marka Crittenden, et al.
Endocrinology|August 2, 2008
Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanismsJames L Trevaskis, Todd Coffey, Rebecca Cole, et al.
Journal for Immunotherapy of Cancer|December 21, 2017
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancerRachel E Sanborn, Helen J Ross, Sandra Aung, et al.
Cancer Research|November 2, 2013
OX40 is a potent immune-stimulating target in late-stage cancer patientsBrendan D Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, et al.
Antiviral Research|February 1, 2026
Analysis of Ibuzatrelvir's Activity Against SARS-CoV-2 Circulating Variants and In Vitro Resistance MutationsIrina Yurgelonis, Devendra K Rai, Zhenghui Li, et al.
NPJ Vaccines|July 6, 2026
Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccineChaitanya Kurhade, Wei Chen, Weiqiang Li, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The AAPS Journal|April 5, 2017
Erratum to: Systematic Verification of Bioanalytical Similarity Between a Biosimilar and a Reference Biotherapeutic: Committee Recommendations for the Development and Validation of a Single Ligand-Binding Assay to Support Pharmacokinetic AssessmentsJoseph C Marini, Michael Anderson, Xiao-Yan Cai, et al.
The AAPS Journal|October 4, 2014
Systematic verification of bioanalytical similarity between a biosimilar and a reference biotherapeutic: committee recommendations for the development and validation of a single ligand-binding assay to support pharmacokinetic assessmentsJoseph C Marini, Michael Anderson, Xiao-Yan Cai, et al.
Science Translational Medicine|June 8, 2012
Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responsesSteven K Seung, Brendan D Curti, Marka Crittenden, et al.
Endocrinology|August 2, 2008
Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanismsJames L Trevaskis, Todd Coffey, Rebecca Cole, et al.
Journal for Immunotherapy of Cancer|December 21, 2017
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancerRachel E Sanborn, Helen J Ross, Sandra Aung, et al.
Cancer Research|November 2, 2013
OX40 is a potent immune-stimulating target in late-stage cancer patientsBrendan D Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, et al.
Antiviral Research|February 1, 2026
Analysis of Ibuzatrelvir's Activity Against SARS-CoV-2 Circulating Variants and In Vitro Resistance MutationsIrina Yurgelonis, Devendra K Rai, Zhenghui Li, et al.
NPJ Vaccines|July 6, 2026
Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccineChaitanya Kurhade, Wei Chen, Weiqiang Li, et al.
Pageof 3